chrisvoncsefalvay/vaers-outcomes huggingface dataset:
brain fog; This is a spontaneous report from a contactable nurse (patient herself). A 29-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via intramuscular route of administration on 26Jan2021 at 15:45 (at the age of 29-year-old) as single dose in right arm for COVID-19 immunisation at hospital. The patient's medical history and concomitant medications were not reported. Patient was not pregnant at the time of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE; Lot Number: Unknown), via intramuscular route of administration on an unknown date in Jan2021 at 01:30 PM (at the age of 29-year-old), as single dose in right arm for COVID-19 immunisation. Patient had no allergies. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. On 29Jan2021, the patient experienced brain fog. The patient did not receive any treatment for the adverse event. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The clinical outcome of the event was not recovered.  Follow-up attempts have been completed and no further information is expected.
I lost passed out and hit the bathtub. Woke up from the pain of the fall, and immediately passed out again, reportedly snoring with my eyes open.  When I was able to get up, I was unable to see. I could only see light and dark. I could not see anything in front of me. For the record, I don not believe I hit my head when I fell. I had no head pain, ever. I then fell asleep and was unable to be aroused for many hours. To this date, I am still having vision problems.
There was no adverse event other than the fact that Hep A Dose #2 was administered 4 months after Dose #1, while the minimum interval is 6 months. Phone call with patient 4 days later revealed patient had no adverse reactions to the vaccine, and will return in 6 months to repeat Hep A dose #2.
Throat tightness 5 minutes after vaccine (swelling feeling and throbbing in throat); didn't feel right. VS stable in dept. and ED. Initially within 8 minutes of symptoms, Benadryl 50IM then transported to ED.
have had the virus in October. fatigue, muscle aches, sore arm, felt hot/fever. Felt like I had the virus again.
diarrhea; weakness; nausea; A spontaneous report was received from a consumer concerning a 92-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced diarrhea,  asthenia, and nausea.  The patient's medical history included back and body pain. Products known to have been used by the patient, within two weeks prior to the event, included warfarin, oxycodone, acetylsalicylic acid, and hydrocodone.  On 09 Feb 2021, prior to the onset of the events, the patient received her first of two planned doses of mRNA-1273 (Lot number: 007M20A) for prophylaxis of Covid-19 infection.   The patient stated that she is experiencing weakness, nausea, and had diarrhea. No further information was provided. Treatment information was unknown.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The events, diarrhea, weakness, and nausea, were considered not recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the reported events, a causal relationship cannot be excluded. Nausea is consistent with the known safety profile of mRNA-1273.  However asthenia is confounded by concomitant use of  oxycodone  and hydrocodone and patient's advanced age.
Information has been received from a licensed pratical nurse referring to an unspecified number of patients of unknown age and gender. On unspecified dates, an unspecified number of patients were vaccinated with doses of RECOMBIVAX HB (dose, frequency, route and lot # were not reported), which were exposed to a temperature excursion. No adverse experience had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
One week after booster vaccine on 11/01/21 (Original was give on 03/06/2021 - Johnson & Johnson) I began to have ringing in both ears. They did not last for long duration but would come and go. Two weeks without any sign of frequency increasing of the episodes the ringing is now 24/7 in both ears.
Patient felt dizzy right after vaccination. Patient stayed for 15 minutes then left. About 7 hours post vaccination patient developed fever and vomiting. Patietnt followed up on 6/21/10 still with on and off fever. Temp 101.6 in the clinic and still vomited 1x that day with episodes of dizziness.
The vaccine recipient was already diagnosed with Alzheimer's but was in an early stage of the condition and able to live independently.  Beginning the day after the vaccine there was a marked and sudden cognitive impairment that severely affected ability to live independently, with (subjectively) worse memory, confusion, mood swings and anger outbursts, and loss of ability to do routine household tasks that she was previously able to do consistently without difficulty (e.g. making coffee, writing checks, heating up a frozen meal).   This gradually improved over the next two months.  She has now (as of April 17, 2021) returned to her pre-shot baseline level of function.  Based on this event we have chosen not to subject her to the risk of a second shot.
Feels a little weaker/ a little weak like after the Flu shot; Feels a little weaker/ a little weak like after the Flu shot; This is a spontaneous report from a contactable nurse (patient). A 75-years-old female patient received the second dose of of BNT162B2 (PFIZER-BIONTECH COVID-19, Batch/lot number: EK5730), via an unspecified route of administration on 06Jan2021 at 0.3 mL single (reported as 0.3cc injection) for covid-19 immunization (reported as works with COVID patients on daily basis). Medical history included hypertension, hip replacement from an accident four years before 07Jan2021 in December (Dec2016). The patient was not overweight, exercises, was older, but considered in good health. The had labs in Dec2020 and everything was ok. The patient's concomitant medications were not reported. The past vaccine event included weak after the Flu shot and first dose BNT162B2 on 16Dec2020 (75-years-old) and experienced dental implants and bridge fell out, bones were hurting her, pain in hip. It was reported on 06Jan2021 1PM (06Jan2021 13:00) was kind of weak. And felt a little weaker on 06Jan2021 and 07Jan2021. She did not have a temperature. She wants to know if this only happened to her or if it was a coincidence. She felt ok, but a little weak like after the Flu shot. The event outcome was unknown.
After the vaccination I had itchiness and sore arm and a week later I got hives.
More than 43 days since 1st dose/Did not receive 2nd dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 43 days since 1st dose/Did not receive 2nd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 43 days since 1st dose/Did not receive 2nd dose). In March 2021, PRODUCT DOSE OMISSION ISSUE (More than 43 days since 1st dose/Did not receive 2nd dose) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
No additional AE; expired dose of MMR II was administered; This spontaneous report was received from a physician referring to a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not provided.  On 28-JAN-2022, the patient was vaccinated with expired dose of measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (rHA) (M-M-R II) (expired product administered) 0.5 milliliter (lot number T001213, expiration date 12-JAN-2022; dose number, vaccination scheme, route of administration, and anatomical location of vaccination were not reported) for prophylaxis.        There was no previous temperature excursion. No product quality complaint (PQC) and no additional adverse event (AEs) was reported.
Developed generalized itching two hours after receiving fluzone. Notified employee health at 4:30pm. Benadryl 25mg ordered. Asumptematic on 11/5/02.
tested positive using a Binx spit test on 31Mar2021; tested positive using a spit test on 31Mar2021; This is a spontaneous report from a contactable consumer (patient). This 65-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the 1st dose (lot number: EL9262) on Jan2021, the 2nd dose (lot number: EN6202) on 25Feb2021; both via an unspecified route of administration in the left arm at single dose for COVID-19 immunisation. Medical history included hypertension (well controlled). Concomitant medications were unknown. The patient had no other vaccine in four weeks, no other medications in two weeks. The patient tested positive using a spit test on 31Mar2021. No treatment was received for events. Outcome of the events was unknown.
pt recv vax & devel an inj site rxn characterized by swelling, redness, warmth, & pain, as well as fever;
CHILLS; FEVER; HEADACHE; NAUSEA; CONGESTION; PAIN IN HANDS; LIGHT HEADEDNESS; BODY ACHES; This spontaneous report received from a patient concerned a 37 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included alcohol consumption, and non smoker, and other pre-existing medical conditions included the patient did not have known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 13:35 for prophylactic vaccination on left arm.. No concomitant medications were reported. On APR-2021, treatment medications included: paracetamol. On 06-APR-2021, the subject experienced light headedness. On 06-APR-2021, the subject experienced body aches. On 06-APR-2021, the subject experienced pain in hands. On 06-APR-2021, the subject experienced headache. On 06-APR-2021, the subject experienced nausea. On 06-APR-2021, the subject experienced congestion. Laboratory data included: Body temperature (NR: not provided) 102 F, 100 F. On 06-APR-2021 02:00, the subject experienced chills. On 06-APR-2021 02:00, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 06-APR-2021, was recovering from fever, headache, nausea, body aches, congestion, and pain in hands, and had not recovered from light headedness. This report was non-serious.
7 days later pt had a large local reaction then on 8 days after shots noticed 2 itchy red spots on both sides of abdomen (pt states she gets this from time to time) -improved over a few days w topical steroids  on day 9 after shot pt had chest pain only with lying down (went to ER) and was diagnosed w GERD a few days later pt had EGD which showed inflammation at GE junction (consistent w GERD)
Patient reports that she was unable to sleep, insomnia, Had a very painful arm at the site of injection applied an ice pack. Felt as if her head was in the fog. She came in to work that Am an noted that she had a sore throat, felt faint, Body aches and LGF of 99.4.  Had the chills and very tired.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There were no pertinent medical history, drug reactions/allergies were reported. On 21-APR-2014 the patient was vaccinated with ROTATEQ lot # H013539, 2 ml, oral expire date reported as 28-MAR-2014 (dose number not reported). No concomitant medications were reported. On 21-APR-2014, the patient was inadvertently administered ROTATEQ lot# H013539 on 21-APR-2014 that had expired on 28-MAR-2014 and experienced no adverse effect. Additional information has been requested.
3 or 4 little bumps on outside edge of each axilla right side worse, no bumps on left - just redness & soreness "biting - stinging" almost gone as of today (10/20/2009) no fever.
rash below injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, several days after receiving Shingrix, the patient experienced injection site rash. On an unknown date, the outcome of the injection site rash was not recovered/not resolved.   It was unknown if the reporter considered the injection site rash to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient herself. The age at vaccination was not reported. The patient received a dose of Shingrix a couple of days ago and developed rash inches below the injection site. The reporter did not consent to follow-up. This case had been linked with case US2019141435, reported by the same reporter.
Individual tested COVID-19 positive on 10/1/2021, after she cared for a positive patient on 9/27/2021. Symptomatic with HA, body aches and congestion since 10/1/2021. Individual to continue isolation from family in separate rooms for ten days and to callback on 10/11/2021. She is undecided regarding antibody testing. Emailed and voicemail left.
PATIENT WAS SITTING IN OBSERVATION ROOM. HE GOT LIGHT-HEADED AND PALLOR IN APPEARANCE. HE STATED HE FELT NAUSEA AND THEN FELT LIKE PASSING OUT. WE TOOK HIS VITALS SIGNS, BP WAS 85/60 P-65 AND O2 SAT 98%. SKIN WAS CLAMMY AND COOL. WE APPLIED AN ICE PACK TO HIS NECK AND HAD HIM LAY DOWN ON FLOOR WITH FEET ELEVATED. AT 3:42 PM HE FELT BETTER, BP WAS 98/70, P-87 AND O2 SATS WERE 98%.
Progressive swelling and pain around and below the right knee, first noticed 11 days after second covid vaccination.
Blur; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blur) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     no medical history was provided.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VISION BLURRED (Blur). At the time of the report, VISION BLURRED (Blur) outcome was unknown.            No concomitant medication was reported , No treatment medication was reported .   Reporter did not allow further contact
After vaccination, patient collapsed to floor - fainting lasted 5 seconds or less.  BP 118/80, no dizzness, nausea, headache.  Left with mother walked out of clinic.
History of Present Illness 73-year-old female with past medical history lupus, diabetes, hypertension, asthma presenting with shortness of breath.  Patient is presenting with approximately 1 day of shortness of breath.  She was reportedly diagnosed positive for Covid 2 days ago.  She was here earlier where she received monoclonal antibody treatment.  EMS was called to her home and found her hypoxic to the 80s and put her on nonrebreather with improvement in oxygen saturation.  She is reportedly fully vaccinated against Covid. Denies fever, chills, chest pain, N/V, urinary/bowel symptoms, weakness
Within 24 hours, patient developed an area of erythema on left thigh 16cmx9.5cm. Warm, pruritic. No fevers, Gail WNL.
Severe cold chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Severe cold chills) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced CHILLS (Severe cold chills). On 03-Mar-2021, CHILLS (Severe cold chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: NNI TCR attached.
Information has been received from an investigator via DAIDS concerning a patient who was enrolled in a study. On an unspecified date the patient was vaccinated with a dose of PNEUMOVAX 23 (Lot not reported) and a dose of hepatitis B virus vaccine rHBsAg (manufacturer unknown). This report was part of a post-marketing surveillance program. At week 1, the patient experienced edema (grade 3), swelling (grade 3) and induration (grade 3). The reporting investigator felt that edema (grade 3), swelling (grade 3) and induration (grade 3) were possibly related to PNEUMOVAX 23 and were not related to hepatitis B virus vaccine rHBsAg (manufacturer unknown. Edema (grade 3), swelling (grade 3) and induration (grade 3) were considered to be an other important medical event. No further information is available.
Pt recieved the Janssen vaccine.  Roughly ten minutes after administration of vaccine pt states that she has left arm knumbness and tingling.  Pt evaluated and vitals stable.  Pt states she has not other means to get to hospital and would like transport by ambulance.  Pt states she has never had an adverse reaction or any issues with her left arm.
patient received a third dose of BNT162b2; patient was positive for COVID-19 on an unknown date and had received all three Pfizer vaccines; patient was positive for COVID-19 on an unknown date and had received all three Pfizer vaccines; This is a spontaneous report received from a contactable reporter(s) (Pharmacist).  A patient (no qualifiers provided) received three doses of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Numbers: UNKNOWN) as single doses for COVID-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: the patient experienced drug ineffective and COVID-19. The patient was positive for COVID-19 on an unknown date and had received all three Pfizer vaccines. The clinical outcomes of drug ineffective and COVID-19 were unknown.   The lot numbers for bnt162b2 were not provided and will be requested during follow up.  Amendment: This follow-up report is being submitted to amend previous information: amended patient data, relevant medical history, suspect vaccine, event description and narrative information.  Follow-up (12Jan2022): This is a follow-up report to notify that the case 202101873835 and case 202200055538  are duplicates.  All subsequent follow-up information will be reported under Manufacturer report number 202200055538.; Sender's Comments: As there is limited information in the case provided, the causal association between the events Covid 19, Drug Ineffective, and immunisation and the suspect drug cannot be excluded. The case will be reassessed once new information is available.
On 03-23-21, I woke up I felt a pulse and y dialysis access and there was no pulse which indicates that the graft has become clotted. I went to the dialyses center contacted dr. and he said I needed to go to another town, to get surgery to clear the clot with another Dr. I flew there had surgery to clear the surgery, surgery was success. I went to dialysis that night, when I checked the graft again it was clotted. I then had to go make arrangements again to fly to another town to get surgery again with Dr. to clear the clots. Surgery was successful and subsequently and I have had a good pulse on my dialysis access.
Following her injection with the influenza vaccine FLUCELVAX-QUADRIVALENT, with a Lot no. 195220, she described experiencing: Some slight tingling in her tongue and a feeling of hot in her arm region. Thereafter, she got lightheaded and dizzy and felt flushed. She felt like her heart was racing and her whole body was hot, although she did not have a fever. Thereafter her arm got red and swollen, which was about 45 minutes later. Subsequently, she went to urgent care, and they administered BENADRYL, and watched her for some time. She did get better, and went home and fell asleep. Over the weekend, she described being itchy in her skin, which has abated some, but she still has some slight itchiness increased, over normal.
First there were nasal issues, then slurring of speech, then difficulty swallowing, dry mouth which then turned into excessive saliva. Weakness on My left side (leg and arm) difficulty walking without support.
patient experienced shortness of breath about 2 minutes after giving the shot. pt also later (in maybe 10 minutes) became nauseated and dizzy
Fever lasting about 24 hours 102.5° highest. Given acetaminophen which brought fever down. At the same time developed a large canker sore on the inside of the lip.
Body aches; fatigue; chills; headache; rash on hands and arms; shaking; soreness at injection site; This is a spontaneous report from a contactable healthcare professional (patient). This 42-year-old female patient received dose 2 of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE; lot number EN5318) via an unspecified route of administration on 11Feb2021 at 11:00 (at the age of 42-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history was none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. The patient did not take any concomitant medications. The patient previously received acetaminophen, propoxyphene (DARVOCET), cephalexin, and pineapple and experienced allergy. The patient previously received dose 1 of BNT162B2 (lot number EL3249) on 21Jan2021 at 11:00 as a single dose in the left arm for COVID-19 immunization. After dose 2 of BNT162B2, on 12Feb2021 at 04:00 the patient experienced body aches, fatigue, chills, headache, rash on hands and arms, shaking, and soreness at injection site. The events were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcomes of body aches, fatigue, chills, headache, rash on hands and arms, shaking, and soreness at injection site were recovered. It was also reported that since the vaccine the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.